RankAlpha logo
Back to Rankings

TXMD

TherapeuticsMDD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
TXMD vs peer average
53/100
TXMD vs. peer average (D vs. D)
Grade spread
A 1 · C 1 · D 3 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ATOS is the first available peer comparator.

Loose micro-cap biotech comparator; useful mainly for event volatility, not operating-model read-through.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerATOSAtossa Therapeutics
TXMD
TherapeuticsMD
ATOS
Atossa Therapeutics
Grade
D
F
Momentum
86
2
Value
54
41
Sentiment
44
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs ATOS

TXMD / ATOS
Grade Position
In line
TXMD vs. peer average (D vs. D)
53/100
Momentum
86
TXMD
Value
54
TXMD
Sentiment
44
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TXMD
1
ATOS
ATOS
F
20/100
+1
2
LGVN
LGVN
F
20/100
+1
3
MDXH
MDXH
F
20/100
+1
4
QCLS
Q/C Technologies Inc Common
F
20/100
+1
5
PLRZ
Polyrizon Ltd Common
D
40/100
Even
ATOS is the first peer returned for this comparison set.